[Federal Register Volume 75, Number 223 (Friday, November 19, 2010)]
[Notices]
[Pages 70932-70933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-29280]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]


Joint Meeting of the Anesthetic and Life Support Drugs Advisory 
Committee and the Drug Safety and Risk Management Advisory Committee; 
Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Joint Meeting of the Anesthetic and Life Support Drugs 
Advisory Committee and the Drug Safety and Risk Management Advisory 
Committee scheduled for December 2, 2010, is cancelled. This meeting 
was announced in the Federal Register of November 1, 2010 (75 FR 
67093). This meeting has been cancelled because the Agency believes the 
information received from previous advisory committee meetings is 
adequate to allow the Agency to address the specific concerns in the 
application that were delineated in the Federal Register notice of 
November 1, 2010.

FOR FURTHER INFORMATION CONTACT: Kalyani Bhatt, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 31, rm. 2417,

[[Page 70933]]

Silver Spring, MD 20993-0002, 301-796-9001, FAX: 301-847-8533, e-mail: 
[email protected], or FDA Advisory Committee Information Line, 
1-800-741-8138 (301-443-0572 in the Washington, DC area), codes 
3014512529 or 3014512535. Please call the Information Line for up-to-
date information on this meeting.

    Dated: November 15, 2010.
Joanne Less,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-29280 Filed 11-18-10; 8:45 am]
BILLING CODE 4160-01-P